Key Dates

Related Announcements

• September 11, 2023 - Intervention Research to Improve Native American Health (R34 Clinical Trial Optional). See NOFO PAR-23-285.
• September 11, 2023 - Intervention Research to Improve Native American Health (R01 Clinical Trial Optional). See NOFO PAR-23-298.
• September 11, 2023 - Intervention Research to Improve Native American Health (R21 Clinical Trials Optional). See NOFO PAR-23-299.

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This notice is to inform potential applicants who may apply for the Intervention Research to Improve Native American Health (IRINAH) Program (R01 PAR-23-298, R21 PAR-23-299, and R34 PAR-23-285) that NIH will conduct an informational webinar on Jan 25, 2024 at 01:00 PM in Eastern Time (US and Canada).

Webinar Goals

• Explain the goals and objectives of the notices of funding opportunities (NOFOs).
• Highlight what’s new with the IRINAH NOFOs relative to prior IRINAH NOFOs, including the addition of an R34 mechanism and non-responsiveness criteria.
• Answer questions from attendees.

Webinar Information

Date: January 25, 2024
Time: 01:00 PM in Eastern Time (US and Canada)

To join the Webinar, registration is required through Zoom.gov at: https://nih.zoomgov.com/webinar/register/WN_IsBBihjJT0ipI73z0vYIhQ#/registration

Specific webinar information including the webinar link will be provided upon registration. The webinar materials will be available after the webinar.

Participation in this webinar, although encouraged, is not required for the submission of an application in response to the NOFOs.

For more information about IRINAH, please visit: https://cancercontrol.cancer.gov/native-american-intervention

Inquiries

Please direct all inquiries to:

Alexa Romberg Ph.D.
National Institute on Drug Abuse (NIDA)
Phone: 301-435-0264
Email: alexa.romberg@nih.gov

Sarah Vidal, Ph.D.
National Institute on Drug Abuse (NIDA)
Phone: 301-827-5529
Email: sarah.vidal@nih.gov